Martin Swarbrick
Director R&D Chemistry at Ryvu Therapeutics- Claim this Profile
Online Presence
Contact Information
us****@****om
(386) 825-5501
Gold Feature
Click to upgrade to our gold package
for the full feature experience.
Location
Greater Cambridge Area, UK
Topline Score
Bio
Generated by
Topline AI
No reviews to display
There are currently no reviews available.
No reviews to display
There are currently no reviews available.
No reviews to display
There are currently no reviews available.
No reviews to display
There are currently no reviews available.
0
/5.0 / Based on 0 ratingsFilter reviews by:
No reviews to display
There are currently no reviews available.
No reviews to display
There are currently no reviews available.
No reviews to display
There are currently no reviews available.
No reviews to display
There are currently no reviews available.
You need to have a working account to view this content.
Click here to join now
Experience
-
Ryvu Therapeutics
-
Poland
-
Biotechnology
-
100 - 200 Employee
-
Director R&D Chemistry
-
Jun 2021 - Present
-
-
-
University of Reading
-
United Kingdom
-
Higher Education
-
700 & Above Employee
-
Visiting Senior Fellow
-
2014 - Present
-
-
-
American Association for Cancer Research
-
United States
-
Non-profit Organizations
-
100 - 200 Employee
-
Chemistry in Cancer Research Working Group Communications Subcommittee Member (Chair 2022-24)
-
Jan 2018 - Present
-
-
-
Royal Society of Chemistry
-
United Kingdom
-
Non-profit Organizations
-
700 & Above Employee
-
Biological and Medicinal Chemistry Sector Committee Member
-
2013 - Present
-
-
-
Society for Medicines Research
-
United Kingdom
-
Pharmaceutical Manufacturing
-
Committee Member
-
Jan 2019 - Present
-
-
-
Cancer Research UK (CRUK)
-
United Kingdom
-
Non-profit Organizations
-
700 & Above Employee
-
Associate Director
-
Nov 2008 - Jun 2021
Cambridge, UK Led the Chemistry, DMPK and Protein Sciences and Structural Biology functions at CRUK Therapeutic Discovery Laboratories. Interim head of Screening and Compound Profiling (07/20-04/21.)
-
-
-
-
Organic Division Executive Committee Member
-
Jul 2008 - Jun 2011
-
-
Heterocyclic and Synthesis Group Committee Member
-
Jan 2006 - Dec 2008
-
-
-
GlaxoSmithKline
-
United States
-
Investment Management
-
Senior Team Leader, Medicinal Chemistry and Lead Optimisation Project Leader
-
Aug 1999 - Oct 2008
-
-
-
University of Montreal
-
Canada
-
Higher Education
-
Post Doc
-
Jan 1998 - Jul 1999
-
-
Education
-
Université de Montréal
Post Doc, Chemistry -
The University of Sheffield
PhD, Chemistry -
The University of Sheffield
BSc, Chemistry -
Hutton Grammar School, Preston, UK
High School
Community
You need to have a working account to view this content.
Click here to join now